NCT00049504 2017-05-17Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled 10 charts
NCT01177371 2010-08-09High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCase Comprehensive Cancer CenterPhase 2 Completed13 enrolled